Alerts will be sent to your verified email
Verify Email
OMKARPH
|
Omkar Pharmachem
|
Guj. Terce Lab
|
ANG Lifesciences
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
2.2 % | 2.73 % | 12.03 % |
|
5yr average Equity Multiplier
|
1.05 | 3.3 | 3.3 |
|
5yr Average Asset Turnover Ratio
|
0.05 | 1.76 | 0.77 |
|
5yr Avg Net Profit Margin
|
44.95 % | -2.57 % | -2.26 % |
|
Price to Book
|
3.15 | 3.96 | 0.49 |
|
P/E
|
350.0 | 0.0 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
49.27 Days | -20.6 Days | 70.26 Days |
|
Inventory Days
|
0.0 | 40.01 Days | 107.37 Days |
|
Days Receivable
|
49.27 Days | 39.02 Days | 274.82 Days |
|
Days Payable
|
0.0 | 100.7 Days | 235.98 Days |
|
5yr Average Interest Coverage Ratio
|
7.4 | 1.07 | 1.81 |
|
5yr Avg ROCE
|
2.6 % | 3.46 % | 15.08 % |
|
5yr Avg Operating Profit Margin
|
44.39 % | -0.49 % | 7.68 % |
|
5 yr average Debt to Equity
|
0.06 | 0.63 | 0.97 |
|
5yr CAGR Net Profit
|
-1.89 % | -17.21 % | n/a |
|
5yr Average Return on Assets
|
2.09 % | -3.57 % | 1.04 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.03 % | 40.03 % | 70.6 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 44.88 % |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 3.81 % | -0.55 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Omkar Pharmachem
|
Guj. Terce Lab
|
ANG Lifesciences
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|